CAR-T

Zixin Lv1,2, Feifei Luo2,3, Yiwei Chu1,2

  • 1Department of Immunology, School of Basic Medical Sciences, and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.

PubMed
概括

全基化化学抗原受体 (CAR) -T细胞疗法在制造上比自身的CAR-T细胞具有优势. 克服移植与宿主疾病和宿主排斥对于其广泛的临床应用至关重要.